Search research articles
Contact Us
Filters
Showing results (21-30 of 76) with videos related to
Page
of 8
Sort By:
Alzheimer'S Research & Therapy
|
March 2, 2016
First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease
Marielle Delnomdedieu, Sridhar Duvvuri, David Jianjun Li, et al.
Journal of Neurology & Neurophysiology
|
August 12, 2017
Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS)
Sabrina Paganoni, Erin McDonnell, David Schoenfeld, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
August 12, 2010
A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis
Nazem Atassi, Eva-Maria Ratai, David J Greenblatt, et al.
Neurology
|
October 10, 2014
The PRO-ACT database: design, initial analyses, and predictive features
Nazem Atassi, James Berry, Amy Shui, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
July 10, 2013
Post-lumbar puncture headache is reduced with use of atraumatic needles in ALS
Colin Quinn, Erik A Macklin, Nazem Atassi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 20, 2018
Head-to-Head Comparison of <sup>11</sup>C-PBR28 and <sup>18</sup>F-GE180 for Quantification of the Translocator Protein in the Human Brain
Paolo Zanotti-Fregonara, Belen Pascual, Gaia Rizzo, et al.
Journal of Huntington'S Disease
|
July 4, 2017
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials
Haruhiko Banno, Kelly L Andrzejewski, Michael P McDermott, et al.
Journal of Huntington'S Disease
|
September 19, 2017
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials
Haruhiko Banno, Kelly L Andrzejewski, Michael P McDermott, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
April 5, 2022
The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies
Luis A Querol, Hans-Peter Hartung, Richard A Lewis, et al.
The Journal of the Acoustical Society of America
|
May 3, 2018
Magnetic resonance imaging based anatomical assessment of tongue impairment due to amyotrophic lateral sclerosis: A preliminary study
Euna Lee, Fangxu Xing, Sung Ahn, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 76) with videos related to
Sort By:
Page
of 8
Alzheimer'S Research & Therapy
|
March 2, 2016
First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease
Marielle Delnomdedieu, Sridhar Duvvuri, David Jianjun Li, et al.
Journal of Neurology & Neurophysiology
|
August 12, 2017
Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS)
Sabrina Paganoni, Erin McDonnell, David Schoenfeld, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
August 12, 2010
A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis
Nazem Atassi, Eva-Maria Ratai, David J Greenblatt, et al.
Neurology
|
October 10, 2014
The PRO-ACT database: design, initial analyses, and predictive features
Nazem Atassi, James Berry, Amy Shui, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
July 10, 2013
Post-lumbar puncture headache is reduced with use of atraumatic needles in ALS
Colin Quinn, Erik A Macklin, Nazem Atassi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 20, 2018
Head-to-Head Comparison of <sup>11</sup>C-PBR28 and <sup>18</sup>F-GE180 for Quantification of the Translocator Protein in the Human Brain
Paolo Zanotti-Fregonara, Belen Pascual, Gaia Rizzo, et al.
Journal of Huntington'S Disease
|
July 4, 2017
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials
Haruhiko Banno, Kelly L Andrzejewski, Michael P McDermott, et al.
Journal of Huntington'S Disease
|
September 19, 2017
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials
Haruhiko Banno, Kelly L Andrzejewski, Michael P McDermott, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
April 5, 2022
The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies
Luis A Querol, Hans-Peter Hartung, Richard A Lewis, et al.
The Journal of the Acoustical Society of America
|
May 3, 2018
Magnetic resonance imaging based anatomical assessment of tongue impairment due to amyotrophic lateral sclerosis: A preliminary study
Euna Lee, Fangxu Xing, Sung Ahn, et al.
Page
of 8